NAMS NewAmsterdam Pharma Company N.V. logo

NAMS NewAmsterdam Pharma Company N.V.

Healthcare
$35.44-0.84%ClosedMarket Cap: $4.14B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

192

13F Shares

118,573,696

Ownership %

99.6%

New Positions

58

Increased Positions

111

Closed Positions

14

Reduced Positions

52

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
SBIOALPS Medical Breakthroughs ETF93,5962.29%
GURUGlobal X - Guru Index ETF19,0361.23%
CGMMCapital Group U.S. Small and Mid Cap ETF435,4790.70%
FMEDFidelity Disruptive Medicine ETF10,7940.59%
VGHCX3,672,4370.33%
VGHAX3,672,4370.33%
IBBiShares Biotechnology ETF537,7840.20%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF32,6180.05%
VHCIX135,5700.02%
VHT135,5700.02%
FHLCFidelity MSCI Health Care Index ETF20,8050.02%
FCNTXFidelity Contrafund977,2960.02%
ONEQFidelity Nasdaq Composite Index ETF33,8790.01%
FADFirst Trust Multi Cap Growth AlphaDEX Fund14,5070.00%
FYCFirst Trust Small Cap Growth AlphaDEX Fund160,4890.00%
FYXFirst Trust Small Cap Core AlphaDEX Fund90,5640.00%